Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression - Related Studies

Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression

This study is ongoing, but not recruiting participants.

Study NCT00093847. Last updated on September 19, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Depression

2	Additional conditions recognized in this trial
		Depressive Disorder

3	More general conditions related to this trial
		Behavioral Symptoms
		Mental Disorders
		Mood Disorders

4	Interventions listed in this trial
		S-adenosyl methione (SAMe)
		Placebo

5	Additional drug interventions recognized in this trial
		Serotonin

6	More general drug interventions related to this trial
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Serotonin Agents

7	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)